Circulating long non-coding RNAs as diagnostic markers of lupus nephritis and 5-year follow-up disease flares
Frontiers in Immunology · 04.08.2026 · 17
DOI: 10.3389/fimmu.2026.1716331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 04.08.2026. Verfasst von Ana Flores-Chova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Lupus Nephritis, RNA, Long Noncoding. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Emerging evidence underscores the pivotal role of long non-coding RNAs (lncRNAs) as epigenetic regulators in the immunopathogenesis of systemic lupus erythematosus (SLE). There is a paucity of comprehensive studies that investigate lncRNA associated with lupus nephritis (LN) and disease flares. Thus, we aimed to identify a specific circulating lncRNA panel with high diagnostic accuracy of LN and predictive power of disease flare incidence.
Methods
To investigate the feasibility of early diagnosis of LN and disease flares, we examined lncRNAs present in plasma obtained from patients with SLE ( n = 96) and healthy individuals (CNT) ( n = 25). Non-coding RNA sequencing analysis was used to determine lncRNA in plasma, and the ability to diagnose renal damage and disease flares in a 5-year follow-up study was estimated by the area under the curve (AUC) and by using multivariate Cox’s proportional hazards regression.
Results
From the ncRNA sequencing results, we identified 9,155 circulating lncRNAs and 148 differentially expressed between patients with SLE and CNT. Seven of these lncRNAs (AL139317.5, AC019080.1, LINC02185, LINC00708, AC239868.1, AC087392.4, and LATS2-AS1) presented statistically significant high expression for the discrimination of the LN (AUC ≥ 0.90), along with high specificity and positive predictive values (≥80%). A panel combining the 7-lncRNA gave an AUC that improved the read count of the single lncRNAs (1.000, p < 0.00001). In addition, six of these lncRNAs were associated with disease flares (AUC ≥ 0.64) and the 4-lncRNA panel was an independent predictor of disease flares (odds ratio = 8.71, p = 0.005 with a c statistic of 0.864, p < 0.0001), with high levels being a strong independent predictor of 60-month follow-up flares (hazard ratio 4.75, p = 0.005). Higher plasma 4-lncRNA panel values were also related to shorter time free of lupus flares. Finally, functional pathway analysis revealed that the lncRNA–miRNA–target gene network was linked to various inflammation pathways (MAPK, JAK-STAT, and p53 signaling pathways) in immune dysregulation and tissue damage in SLE (TGF-β signaling) and regulation of actin cytoskeleton (adherens junction and focal adhesion).
Conclusions
We identified, for the first time, a specific lncRNA expression profile associated with renal damage and an increased incidence of 5-year follow-up disease flares in patients with SLE, being excellent predictive biomarkers for disease activity and organ damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, Valencia, Spain.
- CIBER of Cardiovascular diseases (CIBERCV), Madrid, Spain.
- Internal Medicine Unit, Hospital Clinico Universitario de Valencia, Valencia, Spain.
- Department of Medicine, University of Valencia, Valencia, Spain.
- CIBER Diabetes and Metabolic Associated Diseases (CIBERDEM), Valencia, Spain.
Zitieren
APA
Flores-Chova, A., Martinez-Arroyo, O., Mendez-Debaets, M., Escriva, L., Ortega, A., Forner, M. J., & Cortes, R. (2026). Circulating long non-coding RNAs as diagnostic markers of lupus nephritis and 5-year follow-up disease flares. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1716331
Vancouver
Flores-Chova A, Martinez-Arroyo O, Mendez-Debaets M, Escriva L, Ortega A, Forner MJ, et al. Circulating long non-coding RNAs as diagnostic markers of lupus nephritis and 5-year follow-up disease flares. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1716331
BibTeX
@article{FloresChova2026,
author = {Flores-Chova, Ana and Martinez-Arroyo, Olga and Mendez-Debaets, Marta and Escriva, Lesley and Ortega, Ana and Forner, Maria J and Cortes, Raquel},
title = {Circulating long non-coding RNAs as diagnostic markers of lupus nephritis and 5-year follow-up disease flares},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1716331}
}
EUVIMED